Heartflow @Heartflow

Heart disease is the leading cause of death in the U.S., but it is also one of the most manageable conditions in cardiovascular medicine. The key is getting ahead of it. Heartflow gives cardiologists like Dr. Dharmesh Patel a clearer picture of plaque volume and composition in coronary vessels — enabling earlier, more targeted intervention. For patients with CAD, that insight can be life-changing. Leaders like Richard Smith, COO International & CEO of Airline Operations at FedEx, know this well. Discover how Heartflow supports a more proactive approach to cardiovascular care: heartflow.com/patients-cad/p… #AIinHealthcare #Cardiology #PlaqueAnalysis #HeartHealth

Join us at #SCCT2026 for our educational reception, “From the Heart,” on July 10 from 7:30-9:30 p.m. at Marzul Coastal Cuisine. Hear from our Chief Medical Officer, Dr. Campbell Rogers, as he shares his perspective on the future of advanced imaging and what’s next for cardiovascular care, followed by an opportunity for questions and conversation. Reserve your spot: events.heartflow.com/en/E0aC836/scc… #PlaqueAnalysis #AIinHealthcare

Heading to San Diego for #SCCT2026? Join us for an exciting lineup of educational sessions, expert discussions, and data presentations focused on the latest advances in diagnosing and managing CAD. Be sure to stop by Booth 101 to see what’s new and participate in the DECIDE challenge featuring Heartflow Plaque Staging: event.heartflow.com/scct. See you there! #PlaqueAnalysis #yesCCT

After cardiovascular disease impacted his father, Richard Smith, COO International & CEO of Airline Operations at FedEx, wanted a deeper understanding of his own heart health. A coronary CTA and Heartflow Plaque Analysis helped provide that understanding, revealing significant plaque burden despite otherwise reassuring cardiac test results. Hear more from Dr. Dharmesh Patel as he explains how that level of insight can change the questions physicians ask, the conversations they have with patients, and the treatment decisions they make: heartflow.com/patients-cad/p… Thank you to Stern Cardiovascular Center and East Memphis Imaging for helping us capture Richard’s story and supporting innovative patient care. #AIinHealthcare #Cardiology #PlaqueAnalysis #HeartHealth

How is CCTA changing the way clinicians assess risk and guide cardiovascular care? In a recent CardioNerds podcast episode, Dr. Michael Gallagher joined Drs. @JKassabMD, Mariana Garcia-Arango, and Christopher Mason to explore how CCTA has evolved to integrate physiology through FFRct and biology through AI-driven plaque quantification. Their discussion highlighted landmark evidence from the SCOT-HEART and PROMISE trials, advances in CAD-RADS 2.0 reporting, and the growing role of AI in personalizing patient care. Tune in to the full episode here: cardionerds.com/451-ccta-ct-ff… #AIinHealthcare #YesCCT

Join us at 3:00 p.m. CDT on Thursday, June 11, in Sheraton Ballroom II for an exciting expert theater at #NLA2026. We’ll explore how coronary CTA and Heartflow Plaque Analysis are advancing personalized cardiovascular prevention. Drs. Sarah Rinehart and Nihar Desai will examine the evolving role of plaque analysis in risk stratification—including how to identify patients who stand to benefit most, practical considerations for clinical integration, and what’s next for plaque-focused prevention strategies. We hope to see you there. #AIinHealthcare #PlaqueAnalysis #yesCCT

Heading to #NLA2026 in Chicago? Stop by Booth 301 to connect with our team to see how we’re helping clinicians advance personalized cardiovascular prevention. We’re looking forward to connecting! #AIinHealthcare #PlaqueAnalysis #yesCCT

Attending @AHNtoday's 26th Annual Cardiovascular Disease Symposium in Bedford, PA? Join us for a lunch symposium on Saturday, May 30, at 12:30 p.m. EDT in the Eisenhower Ballroom. Dr. @TaylorMHVIcard will discuss how CCTA and Heartflow Plaque Analysis can support risk stratification, identify the right patients, integrate into clinical workflows, and shape the future of plaque-focused prevention. #PlaqueAnalysis #AIinHealthcare #yesCCT

Former NFL QB @stevebeuerlein partnered with Heartflow to receive our AI-powered heart analysis. Just like great quarterbacks can predict what’s coming on the field, this first-of-its-kind technology helps identify what’s ahead for your heart. Learn more: Heartflow.com/Football

keyboard_arrow_left Previous keyboard_arrow_right Next

Exciting to see the @ChristHospital GAMEFILM site featured on @SpectrumNews1OH in Cincinnati, showcasing their work as part of this nationwide study. The segment highlights Dr. @djkereiakes and his team’s contributions to advancing cardiovascular research in former NFL, NHL and NBA players, including the use of advanced cardiac imaging and Heartflow Plaque Analysis to deepen the understanding of long-term heart health. Watch the full segment here: spectrumnews1.com/oh/cincinnati/… #GAMEFILMRegistry #HeartHealth #GridironGreats

Exciting new updates to Heartflow Plaque Analysis are now available, designed to improve plaque visualization and help simplify reporting workflows. The enhanced PDF now includes structured reporting to support streamlined dictation, along with a patient-specific 3D model that provides a clearer view of plaque distribution, characterization and burden. #PlaqueAnalysis #AIinHealthcare

Physicians have spent decades looking at the heart like plumbers, focusing only on the narrowing of the pipe. But the story of CAD is evolving into something more comprehensive. Dr. Gibson reflects on this shift: “We have moved away from just being plumbers… to now this fully functional assessment of the wall and the flow here 30 years later. I think we’re getting there.” We’re proud to be a leader in the movement that is finally giving clinicians the full picture of patient health. Watch the full video here: heartflow.com/insight/reimag… #AIinHealthcare #yesCCT

There’s often a significant gap between what physicians see with a standard “eyeball” read and what’s actually happening in the vessels. Dr. Wood recounts a powerful case where Heartflow technology provided the necessary clarity: “The initial read was a moderate stenosis… the FFRct pointed us to the fact that he had severe disease in these vessels, and he underwent a CABG. It made a huge difference.” AI-driven intelligence is about finding those life-changing insights that traditional assessments might miss: heartflow.com/insight/reimag… #AIinHealthcare #FFRct

Our experiential DECIDE demo at #ACC2026 was a hit and reinforced what we’ve seen in the DECIDE Registry: when clinicians have access to Heartflow Plaque Analysis, their risk and management decisions change. In DECIDE, a management change was reported in over 50% of cases. At ACC, our demo saw clinicians change a patient’s risk profile in over 65% of cases. Want to know your patients as well as Heartflow does? It’s time to look into Plaque Analysis: heartflow.com/heartflow-one/… #PlaqueAnalysis #AIinHealthcare

When we look at the results of the PACIFIC study, the diagnostic accuracy of FFRct stands out compared to traditional testing. As Dr. Malissa Wood puts it: “The accuracy of the diagnosis of significant coronary disease was best with CT and FFRct. That really helped me feel more confident in utilizing CT as a first-line modality”. Watch the full video here and learn how Heartflow data is instilling clinical confidence: heartflow.com/insight/reimag… #yesCCT #AIinHealthcare #FFRct

We are excited to see Dr. @ziadalinyc and his team at @StFrancis_LI using Heartflow PCI Navigator to bring new levels of precision to patient care in the cath lab. This work is a great example of the real-world impact we are seeing through the NAVIGATE PCI registry, which is investigating how pre-procedural planning can optimize clinical outcomes. Thank you, Dr. Ali, for leading the way and showing us all what "clarity before cath" really looks like! #PCINavigator #AIinHealthcare

Ziad Ali @ziadalinyc

2 months ago

And we’re off! First HeartFlow NAVIGATE-PCI case. Precision in PCI isn’t just by IVUS/OCT anymore— the standard has expanded to CT-Guided PCI. NAVIGATE-PCI will test how data-driven tools can optimize decision-making, streamline workflow, and improve outcomes in the cath lab.

keyboard_arrow_left Previous keyboard_arrow_right Next

5 32 143 17K 24

And we’re off! First HeartFlow NAVIGATE-PCI case. Precision in PCI isn’t just by IVUS/OCT anymore— the standard has expanded to CT-Guided PCI. NAVIGATE-PCI will test how data-driven tools can optimize decision-making, streamline workflow, and improve outcomes in the cath lab. Optimal PCI is guided, precise, data-driven inside #ctguidedpci or outside #imagefirst the lab @Heartflow @StFrancis_LI @ESHLOF @DrAllenJ @djc795 @DoosupShin @rooshaparikh @OKhaliqueMD @CathElectroSurg @JWMoses @ColletCarlos @yadersandoval @manosbrilakis @kalazizimd

keyboard_arrow_left Previous keyboard_arrow_right Next

How are the latest advances in AI reshaping cardiovascular programs? Join our breakfast symposium to hear how CV service line leaders are integrating Heartflow Plaque Analysis into their strategic planning. We’re diving deep into operational implementation, financial considerations, and physician alignment to help you support program growth and clinical quality. Don't miss these practical insights into the evolving landscape of CAD management! #AIinHealthcare #PlaqueAnalysis

Join Drs. @RonBlankstein and @ToddVillinesMD for a sponsored webinar with @Heart_SCCT on Wednesday, April 29th to explore the latest evidence behind CCTA and AI-driven plaque analysis. With recent endorsements from major cardiovascular societies, it’s a perfect time to discuss how these tools are becoming essential for modern patient management. This session will dive into the clinical data and provide practical steps for integrating plaque analysis into your daily practice to help identify high-risk patients earlier. Register now: scct.org/events/EventDe… #PlaqueAnalysis #yesCCT

We’re looking forward to welcoming cardiology and radiology professionals at the Heartflow EMEA Users’ Meeting at the Royal College of Surgeons in London for a full day dedicated to the future of coronary care. The program has been thoughtfully designed to provide a comprehensive view of the latest developments in CAD — combining clinical insights, innovation updates, and interactive discussions with leading experts, including Jonathon Leipsic, Tim Fairbairn, Alan Bagnall, and Pál Maurovich-Horvat. Join us for an upcoming engaging and insightful event. Connect with your Heartflow representative to find out how to participate. #Cardiology #Radiology #Innovation